Ethical issues in the relationships with industry: An ongoing challenge. New Guidelines open for public comment

Journal of Paediatrics and Child Health

Volumn 41, Issue 11, 2005, Pages 558-560

  Komesaroff, P A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Conflicts of interest; Ethics; Pharmaceutical industry

Indexed keywords

AUSTRALIA; CLINICAL PRACTICE; CLINICAL RESEARCH; CONFLICT OF INTEREST; DRUG INDUSTRY; MEDICAL ETHICS; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SOCIAL WELFARE; ARTICLE; ETHICS; GENERAL PRACTITIONER; HUMAN; MEDICAL RESEARCH; PUBLIC HEALTH;

AUSTRALIA; BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; DRUG INDUSTRY; GUIDELINES; HUMANS; NATIONAL HEALTH PROGRAMS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY;

EID: 33644842804     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2005.00719.x     Document Type: Review

References (23)

1. Breen K. The medical profession and the pharmaceutical industry: When will we open our eyes? Med. J. Aust. 2004 180 : 409 10.
2. Steinbrook R. Conflict of interest at the NIH - resolving the problem. N. Engl. J. Med. 2004 351 : 955 7.
3. Fitzgerald PD. The ethics of doctors and big business. Med. J. Aust. 2001 175 : 73 5.
4. Holmes DR Jr., Firth BG, James A et al. Conflict of interest. Am. Heart J. 2004 147 : 228 37.
5. Komesaroff PA, Bach MA, Danoff A et al. The Endocrine Society Ethics Advisory Committee: Ethical aspects of conflicts of interests. Endocrinology 2004 145 : 3032 41.
6. Wazana A. Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA 2000 283 : 373 80.
7. Peay MY, Peay ER. The role of commercial sources in the adoption of a new drug. Soc. Sci. Med. 1988 26 : 1183 9.
8. Chren MM, Landefeld CS. Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA 1994 271 : 684 9.
9. Rutledge P, Crookes D, McKinstry B, Maxwell SR. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey. Pharmacoepidemiol. Drug Saf. 2003 12 : 663 7.
10. Agrawal S. Pharmaceutical industry and sponsorship of delegates for national conferences. Indian Pediatr. 2002 39 : 445 8.
11. Neumann HA. Is pharmaceutical sponsorship of a dermatologic conference proper? Arch. Dermatol. 1999 135 : 645 6.
12. Razack S, Arbour L, Hutcheon R. Proposed model for interaction between residents and residency training programs, and pharmaceutical industry. Ann. R. Coll. Physicians Surg. Can. 1999 32 : 93 6.
13. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: A systematic review. JAMA 2003 289 : 454 65.
14. Komesaroff PA, Kerridge IJ. Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry. Med. J. Aust. 2002 176 : 118 21.
15. Bero LA, Rennie D. Influences on the quality of published drug studies. Int. J. Technol. Assess. Health Care 1996 12 : 209 37.
16. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. BMJ 2003 326 : 1167 70.
17. Ililch I. Limits to Medicine. London : Marion Boyars, 1977.
18. Moynihan R. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement. BMJ 2003 326 : 1193 6.
19. Moynhian R. The making of a disease: Female sexual dysfunction. BMJ 2003 326 : 45 7.
20. Komesaroff PA, Bach MA, Danoff A et al. The Endocrine Society Ethics Advisory Committee: Ethical aspects of conflicts of interests, October 2003. Endocrinology 2004 145 : 3032 41.
21. Komesaroff PA, Carney S, LaBrooy J, Woodward M, Cohen A, Tattersall M. RACP Guidelines. Sydney : The Royal Australasian College of Physicians, 1999.
22. Komesaroff PA, Carney S, La Brooy J, Tattersall M, Greenberg P, Bruce A et al. (eds). Guidelines for the Relationships Involving Medical Practitioners and Industry, 3rd edn. Sydney : RACP, 2005.
23. Kerridge I, Maguire J, David N et al. Co-operative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organisations. Intern. Med. J. 2005 35.